LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025” – Biogen

Written by

admin

in

  1. LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”  Biogen
  2. How Leqembi’s At-Home Injection Launch at Eisai (TSE:4523) Has Changed Its Investment Story  simplywall.st
  3. Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.  Yahoo Finance
  4. Eisai and Biogen’s LEQEMBI IQLIK™ Named One of TIME’s “Best Inventions of 2025” for Alzheimer’s Treatment  Quiver Quantitative
  5. Gilead’s Yeztugo, Eisai’s Leqembi Iqlik, Vertex’s Journavx among 2025’s best inventions: Time  Fierce Pharma

Continue Reading

More posts